Selexis has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for  two decades.

Latest News

JUNE 1, 2021
2 min read

Selexis Appoints Roland Hoffmann-Hecht, PhD, as Chief Business Officer

Business Development Executive in Biologics Drug Development and Manufacturing Brings More than 25 Years of...

Read More
MAY 27, 2021
3 min read

Great Place to Work® Designates Selexis as One of the Best Workplaces™ Switzerland for Fourth Straight Year

Geneva, Switzerland, May 27, 2021  Selexis SA, a JSR Life Sciences company, announced today that Great Place to Work® ...

Read More
MARCH 23, 2021
4 min read

Selexis and Tallac Therapeutics Collaborate to Advance Tallac’s Pipeline of Novel Immunotherapies in Oncology

Tallac Will Draw on Selexis’ Best-in-Class Cell Line Development Technologies Under New Commercial License and Service...

Read More